A Morning Routine.

Two weeks in a row I post on Tuesday. Apologies again for the tardiness. I’m officially expanding the post window to Monday and Tuesday to give myself a little more breathing room.

Let’s get into it.

The neurotech field is buzzing. It is in labs, in newsrooms, and in founder group chats. We’re seeing headlines about monkeys seeing objects that aren’t there, earbuds reading emotional states, and wearables that claim to sharpen your focus. But here’s the thing:

Most people haven’t used a neurotech product. Fewer still rely on one.

We’re still early. So early, that public perception is being shaped not by what people use, but by what they hear about.

Here’s my hypothesis:

Not the flashiest. Not the one that “reads your mind.” But the one that slides quietly into someone’s day and earns the right to stay there.

Let’s break this down and look at how neurotech’s trajectory might rhyme with (or diverge from) other tech movements.

A few years ago, AR and VR were supposed to be the next big thing. Oculus raised hundreds of millions. HoloLens promised a revolution in the workplace.

But a decade later, most people still don’t own a headset. Even fewer use one every day.

The problem wasn’t technological failure. It was friction. These products asked too much. Users had to change how they moved, how they worked, how they furnished their homes. VR never earned the right to become a habit. It stayed in the realm of demos and demos alone.

Neurotech faces a similar risk. A brain-computer interface might be miraculous in the lab, but if it requires a lengthy setup, invasive surgery, or an hour of calibration, it won’t become part of someone’s Tuesday morning.

People don’t adopt tech because it’s powerful. They adopt it because it fits into their rhythm.

By contrast, look at AI. Specifically, how OpenAI introduced it to the world.

When ChatGPT launched, it didn’t require a new interface or new behavior. It gave people a familiar box and told them to type. No tutorial. No jargon. Just try it.

That simplicity invited experimentation. It lowered the stakes. People used it to brainstorm, debug, journal, joke. It wasn’t just powerful, it was flexible enough to become useful in dozens of different contexts.

That’s what neurotech needs: not just a breakthrough, but a behavior.

It needs its “chat box” moment. A way to meet people where they already are.

Right now, the most well-known name in neurotech is Neuralink. Their work is important, and in many ways, inspiring. Giving a paralyzed person the ability to move a cursor with their mind is not just a technical feat, it’s a human one.

They deserve credit. Full stop.

But it’s worth noting: they’re defining the public imagination not because they’re the only company in neurotech, but because their story travels. Brain surgery. Elon Musk. Mind control. Those headlines write themselves.

That’s not Neuralink’s fault. But for the public, it’s important to recognize: Neuralink is not the entire field.

There are dozens hundreds of neurotech teams around the world working on non-invasive, wearable, ambient, and even software-first neurotech. Their work may not involve implants, but it might be the first to touch millions of people.

Because that’s the thing: media impact isn’t the same as user adoption.

And brain surgery, no matter how futuristic, isn’t going to be a daily experience anytime soon.

So what might?

Here’s where the hypothesis sharpens:

1. It won’t feel like neurotech.It’ll look like a headband. Or an earbud. Or a watch. Something that feels familiar. It won’t demand that people learn a new language or behavior. It’ll just feel like a better way to do something they already care about: sleep deeper, focus longer, and feel calmer.

2. It won’t market itself as neurotech.It won’t ask you to “monitor your alpha waves” or “boost your theta state.” It will talk about the results. “Fall asleep faster.” “Feel more focused without caffeine.” “Unwind before bed.”

Just like Calm doesn’t require you to understand Buddhist meditation, and Fitbit doesn’t require you to know what HRV means, the neurotech that wins will be outcome-forward and not protocol-forward.

There are products testing this direction already.

What these products have in common is not the raw novelty. It’s habit-building. They’re not just tested once and put away. They’re designed to be used again. And again. And again.

They're not trying to impress the lab. They're trying to earn the bedside table.

If you're working on a neurotech product, whether you're a founder, designer, scientist, or investor, here are a few implications of this way of thinking:

1. Design for the tenth use, not the first.Your onboarding matters. But so does the fourth night someone forgets to use it. What pulls them back in? What rewards them for consistency?

2. Anchor to existing routines.Don’t invent a new time of day. Don’t ask for a new ritual. Instead, find a way to fit into one that already exists: morning coffee, wind-down before bed, commute, workout, therapy.

3. Make it feel familiar.Neurotech can feel intimidating, even invasive. Use design to make it feel like any other wellness product: approachable, comfortable, easy to understand.

4. Lead with the benefit, not the biology.Yes, the neuroscience is cool. But most people don’t want to understand a waveform. They want to feel different. Sell that.

We like to imagine tech adoption as a big reveal: an iPhone moment, a moon landing, a CRISPR headline.

But most revolutions start smaller. A nudge. A quiet shift in routine.

That’s what neurotech needs next. Not another demo. Not another billion-dollar round. But a product that becomes invisible. Useful. Repeatable.

Not a breakthrough. A habit.

Until next time,

—Daniel